Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01742143 · ClinicalTrials.gov registry record
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
A clinical trial of Cancer Patients, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 347
- Enrollment target
- 11
- Study locations
NCT01742143 is a study of Cancer Patients that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 347 participants, above the 201-participant average among 8 other Cancer Patients trials with a reported enrollment target (73% higher). The trial reports 11 study locations across 2 states.
The verdict
NCT01742143, a study of Cancer Patients, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 347 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this 1 year study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York City hospitals, like meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital guidance).
Conditions Studied
Interventions
- BEHAVIORAL The Integrated Cancer Care Access Network (ICCAN)
- BEHAVIORAL Usual and Customary Group (U&C)
Study Locations (11)
New York
- Lutheran Medical Center - Brooklyn
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) - Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities) - Harrison
- City College of New York (Data Collection AND Data Analysis) - New York
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities) - New York
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activities) - Rockville Centre
- Lincoln Hospital and Mental Health Center - The Bronx
New Jersey
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2012-11 |
| Est. Completion | 2026-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01742143
The ClinicalTrials.gov registry entry for NCT01742143 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 347 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 201-participant average among 8 other Cancer Patients trials with a reported enrollment target (73% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer Patients appearing as the primary indexed condition, and to 2 interventions - of which The Integrated Cancer Care Access Network (ICCAN) is the first listed.
NCT01742143 reports 11 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT01742143 about?
NCT01742143 is a clinical study titled "Impact of ICCAN on Cancer Treatment Completion and Quality of Life". The purpose of this 1 year study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York City hospitals, like meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital guidance).
What is the current status of trial NCT01742143?
This trial is currently recruiting. The enrollment target is 347 participants. The study started on 2012-11. Estimated completion is 2026-11.
What conditions does trial NCT01742143 study?
This clinical trial studies the following conditions: Cancer Patients.
What interventions are being tested in trial NCT01742143?
The interventions under investigation include: The Integrated Cancer Care Access Network (ICCAN) (BEHAVIORAL), Usual and Customary Group (U&C) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01742143?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01742143 being conducted?
This trial has 11 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Patients
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain
RECRUITING · Phase 1
-
Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity
RECRUITING · NA
-
A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers
RECRUITING · NA
-
Writing Intervention With Adolescents and Young Adults With Cancer
RECRUITING · NA
-
Food: A Three-Arm Study Examining Food Insecurity Interventions
ACTIVE NOT RECRUITING · Phase 2
-
A Study Comparing Two Types of Supportive Interventions for Caregivers of Patients With Cancer
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.